ClexBio
ClexBio is a biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced microfluidics with our proprietary hydrogel technology CLEX.
ClexBio has raised €1.9M across 1 funding round from 5 investors, most recently a Seed round in Jul 2021. Based in Oslo, Norway; active in Healthtech. Data as of 28 Oct 2026.
Oslo, Norwaywww.clexbio.com ↗
Total raised
€1.9M
€1,868,365
Funding rounds
1
Investors
5
distinct backers
Active since
2021-07
latest 2021-07
Funding by year
EUR raised per yearClexBio — funding by year — interactive chart.
Data table
| ClexBio — funding by year | |
|---|---|
| 2021 | €1.9M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-22 | Seed | €1.9M | Angel Investors,Centre for Digital Life Norway,Innovation Norway,Research Council of Norway,UK Engineering and Physical Sciences Research Council | View deal → |
Investors
5Related news
- ClexBio Raises USD 2.2M in Financingt.co · 2021-07
Similar companies
same sector or country- Visma€3.0BNorway · Software
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Adevinta€1.9BNorway · Marketing
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData